Welfens Paul J J
European Economy and International Economic Relations (EIIW), University of Wuppertal, Rainer-Gruenter-Str. 21, D-42119 Wuppertal, Germany.
AICGS/Johns Hopkins University, Washington DC, USA.
Int Econ Econ Policy. 2020;17(2):295-362. doi: 10.1007/s10368-020-00465-3. Epub 2020 May 23.
The novel coronavirus (COVID-19) epidemic represents a major challenge for the world economy. While a detailed longer-term diffusion path of the new virus cannot be anticipated for individual countries, one may anticipate international supply shocks and declining GDP growth in many OECD countries and China in 2020; and one should expect falling asset prices in Asia, the United States and the European Union plus the United Kingdom - except for the price of risk-free government bonds. In the course of 2020/21 the US, the EU and the UK, as well as other countries, will face both an increasing number of infected patients as well as a higher case fatality ratio. Health care expenditures in the US could increase more than in the Eurozone and the EU in the medium term, a development that undermines the international competitiveness of the United States. The analysis suggests that per capita income is a positive function of the effective trade openness and of the new Global Health Security Index indicator from the NTI/Johns Hopkins University. A rising health care-GDP ratio in the US is equivalent to a rising US export tariff. As regards the coronavirus challenge, the ratio of acute care beds to the elderly in OECD countries shows considerable variation. Due to international tourism contraction alone, output growth in the Eurozone, the US and China can be expected to fall by about 1.6% in 2020. The COVID-19 challenge for the US Trump Administration is a serious one, since the lack of experts in the Administration will become more apparent in such a systemic stress situation - and this might well affect the November 2020 US presidential election which, in turn, would itself have considerable impacts on the UK and the EU27 as well as EU-UK trade negotiations. Integrating the health care sector into macroeconomics, which should include growth analysis, is an important task. The role of health quality - and health insurance coverage - for endogenous time horizons and economic welfare, respectively, is emphasized.
新型冠状病毒(COVID-19)疫情对世界经济构成了重大挑战。虽然无法针对个别国家预测这种新病毒详细的长期传播路径,但可以预计2020年许多经合组织国家和中国将面临国际供应冲击和GDP增长下降;而且应该预计亚洲、美国、欧盟以及英国的资产价格将会下跌——无风险政府债券价格除外。在2020/21年期间,美国、欧盟、英国以及其他国家将面临感染患者数量增加和病死率上升的情况。从中期来看,美国的医疗保健支出增长可能超过欧元区和欧盟,这一发展态势会削弱美国的国际竞争力。分析表明,人均收入是有效贸易开放度和NTI/约翰·霍普金斯大学新的全球卫生安全指数指标的正函数。美国医疗保健占GDP比例的上升等同于美国出口关税的提高。就冠状病毒挑战而言,经合组织国家急性护理床位与老年人的比例差异很大。仅由于国际旅游业收缩,预计2020年欧元区、美国和中国的产出增长将下降约1.6%。COVID-19对美国特朗普政府来说是一个严峻挑战,因为在这种系统性压力情况下,政府缺乏专家的问题将更加明显——这很可能会影响2020年11月的美国总统选举,而这反过来又会对英国、欧盟27国以及欧盟与英国的贸易谈判产生重大影响。将医疗保健部门纳入宏观经济学(应包括增长分析)是一项重要任务。分别强调了卫生质量以及医疗保险覆盖范围对内生时间跨度和经济福利的作用。